The National Academies of Science, Engineering and Medicine today released A Framework for Equitable Allocation of Vaccine for the Novel Coronavirus to assist and guide the federal government and decision-making bodies, including the Advisory Committee on Immunization Practices, as well as state, tribal, local and territorial authorities in their COVID-19 vaccine allocation planning. The report establishes four phases of distribution, with equity a crosscutting consideration.

AHA, which submitted comments on NASEM’s draft of the report, today in a joint statement with the Association of American Medical Colleges praised the final framework as “sensible, well-considered, and most importantly, an equitable way to distribute a vaccine to all Americans.”

The organizations added that steps must be taken to overcome public mistrust.

“The AHA and AAMC strongly urge federal, state, and local government agencies, along with doctors, nurses, and hospitals and health systems, to deploy resources now to engage communities, build trust, create partnerships, and develop the bidirectional communication channels necessary to orient the vaccination effort toward success,” said AHA President and CEO Rick Pollack and AAMC President and CEO David J. Skorton, M.D.

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…